These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11911973)

  • 1. Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy.
    Tsuneizumi M; Emi M; Hirano A; Utada Y; Tsumagari K; Takahashi K; Kasumi F; Akiyama F; Sakamoto G; Kazui T; Nakamura Y
    Cancer Lett; 2002 Jun; 180(1):75-82. PubMed ID: 11911973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.
    Haga S; Emi M; Hirano A; Utada Y; Kajiwara T; Akiyama F; Sakamoto G; Takahashi K; Tada T; Kasumi F; Miki Y; Nakamura Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1199-206. PubMed ID: 11714444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
    Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses as prognostic markers for breast cancers.
    Hirano A; Utada Y; Haga S; Kajiwara T; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Int J Clin Oncol; 2001 Feb; 6(1):6-12. PubMed ID: 11706530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.
    Emi M; Yoshimoto M; Sato T; Matsumoto S; Utada Y; Ito I; Minobe K; Iwase T; Katagiri T; Bando K; Akiyama F; Harada Y; Fukino K; Sakamoto G; Matsushima M; Iida A; Tada T; Saito H; Miki Y; Kasumi F; Nakamura Y
    Genes Chromosomes Cancer; 1999 Oct; 26(2):134-41. PubMed ID: 10469451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer.
    Matsumoto S; Minobe K; Utada Y; Furukawa K; Onda M; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer Lett; 2000 Apr; 152(1):63-9. PubMed ID: 10754207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer.
    Emi M; Utada Y; Yoshimoto M; Sato T; Minobe K; Matsumoto S; Akiyama F; Iwase T; Haga S; Kajiwara T; Sakamoto G; Kasumi F; Nakamura Y
    Breast Cancer; 1999 Oct; 6(4):351-356. PubMed ID: 11091742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
    Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
    Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
    Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
    N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses in localized prostate cancer: association with prognostic factors.
    Fromont G; Joulin V; Chantrel-Groussard K; Vallancien G; Guillonneau B; Validire P; Latil A; Cussenot O
    J Urol; 2003 Oct; 170(4 Pt 1):1394-7. PubMed ID: 14501776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of chromosomal arm 8p in breast cancer progression.
    Anbazhagan R; Fujii H; Gabrielson E
    Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers.
    Lu W; Takahashi H; Furusato B; Maekawa S; Ikegami M; Sudo A; Egawa S; Hano H
    Genes Chromosomes Cancer; 2006 May; 45(5):509-15. PubMed ID: 16470536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
    Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
    Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.